Mariner’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
Mariner's AVEO Position: Q1 2023 in Review
Mariner sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 47,691 shares — an estimated $713K sold.
Mariner first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $713K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Mariner reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Mariner sold 47,691 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $713K.
- Mariner first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
- Mariner's AVEO Pharmaceuticals, Inc. position peaked at $713K in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Mariner's 13F filing for Q1 2023, filed 15 May 2023.